Nectagen is the developer of nanoCLAMP™ technology, an affinity ligand scaffold platform that produces high affinity, highly specific ligands with special properties not found in other antibody mimetics. The nanoCLAMP™ single domain antibody mimetics are comparable to nanobodies, but are compatible with challenging conditions such as high temperature, extremes of pH, organic solvents, NaOH sanitization, and proteases. Nectagen can typically produce custom nanoCLAMPs to nearly any protein target in a matter of weeks.
Nectagen's specialties include affinity purification, affinity chromatography, antibodies, antibody mimetics, protein purification, single step purification, native protein purification, native complex purification, immunoprecipitation, co-immunoprecipitation, immunoaffinity chromatography, and functional proteomics.
Company Details
- Employees
- 4
- Founded
- 2009
- Address
- 2029 Becker Drive,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- nectagen.com
- Keywords
- Affinity Purification, Affinity Chromatography, Nanobodies, Antibody Mimetics, Protein Purification, Single Step Purification, Native Protein Purification, Native Complex Purification, Immunoprecipitation and Co-immunoprecipitation, Immunoaffinity Chromatography.
- HQ
- Lawrence, Kansas
Nectagen, Inc. Questions
Nectagen, Inc.'s website is nectagen.com
Nectagen, Inc.'s LinkedIn profile is https://www.linkedin.com/company/nectagen
Nectagen, Inc. has
4 employees.
View email and phone details for 4
employees at Nectagen, Inc..
Nectagen, Inc.'s industry is
Biotechnology Research
Nectagen, Inc.'s top competitors are
Metamorphosis Gmbh,
Resonant Therapeutics,
Alsal Construction, Inc.,
Recourse Biologics,
Vistech,
Tango International Inc.,
Celerion,
Epics Therapeutics,
Stowers Institute For Medical Research,
Kc Biologics.
Nectagen, Inc.'s categories are Biotechnology Research
Nectagen, Inc.'s founding year is 2009
